Serum uric acid and risk of coronary heart disease

Current Pharmaceutical Design

Volumn 11, Issue 32, 2005, Pages 4125-4132

  Wannamethee, S Goya ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Coronary heart disease; Epidemiology; Hypertension; Risk factors; Serum uric acid

Indexed keywords

ALLOPURINOL; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENZIODARONE; DIURETIC AGENT; LOSARTAN; PURINE; THIAZIDE DIURETIC AGENT; URATE; URIC ACID; XANTHINE OXIDASE;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; HEART FAILURE; HUMAN; HYPERTENSION; HYPERURICEMIA; ISCHEMIC HEART DISEASE; OBESITY; OUTCOMES RESEARCH; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; STROKE; URIC ACID BLOOD LEVEL; VASCULAR DISEASE;

CORONARY DISEASE; FEMALE; HUMANS; HYPERTENSION; MALE; RISK FACTORS; URIC ACID;

EID: 27944465651     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161205774913200     Document Type: Review

References (73)

1. Gertler MM, Garn SM, Levine SA. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med 1951; 34: 1421-31.
2. Klein R, Klein B, Cornoni, Maready J, Cassel JC, Tyroler HA. Serum uric acid: its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Int Med 1973; 132: 401-10.
3. Beard JT. Serum uric acid and coronary heart disease. Am Heart J 1983; 106: 397-400.
4. Brand FN, McGee DL, Kannel WB, Stokes III J, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 1985; 121: 11-8.
5. Dobson A. Is raised uric acid a cause of cardiovascular disease or death? Lancet 1999; 354: 1578.
6. Wannamethee SG. Is serum uric acid a risk factor for coronary heart disease. J Hum Hypertens 1999; 13: 153-6.
7. Johnson RJ, Kivlighn SD, Kim Y-G, Suga S, Fogo A. Reappraisal of the pathogenisis and consequences of hyperuricaemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 1999; 33: 225-34.
8. Johnson RJ, Tuttle KR. Much ado about nothing, or much to do about something? The continuing controversy over the role of uric acid in cardiovascular disease. Hypertension 2000; 35: e10.
9. Rich M. Uric acid: is it a risk factor for cardiovascular disease. Am J Cardiol 2000; 85: 1018-21.
10. Waring WS, Webb DJ, Maxwell SRJ. Uric acid as a risk factor for cardiovascular disease. Q J Med 2000; 93: 707-13.
11. Wannamethee SG. Serum uric acid is not an independent risk factor for coronary heart disease. Curr Hypertens Rep 2001; 3: 190-6.
12. Yusuf S, Bosch J. Urate levels as a predictor of cardiac deaths: causal relation or mere association. Eur Heart J 2002; 23: 760-1.
13. Alderman MH. Uric acid and cardiovascular risk. Curr Opin Pharmacol 2002; 2: 126-30.
14. Johnson RJ, Kang DH, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-90.
15. Alderman M, Aiyer KJ. Uric acid: role in cardiovascular disease and effects of losartan. Curr Med Res Opin 2004; 20: 369-79.
16. Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart 1997; 78: 147-53.
17. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999; 131: 7-13.
18. Liese AD, Hense HW, Lowel H, Doring A, Tietze M, Keil U. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organisation Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology 1999; 10: 391-7.
19. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality. The NHANES I Epidemiologic Follow-up Study, 1971-1992. JAMA 2000; 283: 2404-10.
20. Moriarty JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD. Serum uric acid and risk of coronary heart disease: Atherosclerosis risk in communities (ARIC) Study. Epidemiology 2000; 10: 136-43.
21. Jee SH, Lee SY, Miyong TK. Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men. Eur J Cardiovasc Pevention Rehab 2004; 11: 185-91.
22. Hoieggen A, Alderman M, Kjeldsen SE, Julius S, Devereux RB, de Faire U, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Intnl 2004; 65: 1041-9.
23. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischaemic heart disease: the NHANES I epidemiologic follow-up study. Am J Epidemiol 1995; 141: 637-44.
24. Levine W, Dyer A, Shekelle RB, Schoenberger JA, Stamler J. Serum uric acid and 11.5 year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 1989; 42: 257-67.
25. The Coronary Drug Project Research Group. Serum uric acid: its association with other risk factors and with mortality in coronary heart disease. J Chron Dis 1976; 29: 557-69.
26. Persky VW, Dyer AR, Idris Soven E, Stamler J, Shekelle RB, Schoenberger JA, et al. Uric acid: a risk factor for coronary heart disease? Circulation 1979; 59: 969-77.
27. Reunanen A, Takkunen, Knekt P, Aromaa A. Hyperuricaemia as a risk factor for cardiovascular mortality. Acta Med Scand (Suppl) 1982; 668: 49-59.
28. Yano K, Reed DM, McGee DL. Ten year incidence of coronary heart disease in the Honolulu Heart Program: relationship to biological and lifestyle characteristics. Am J Epidemiol 1984; 119: 653-66.
29. Iribarren C, Sharp DS, Curb JD, Yano K. High uric acid: a metabolic marker of coronary heart disease among alcohol abstainers. J Clin Epidemiol 1996; 49: 673-8.
30. Selby JV, Friedman GD, Queensberry CP. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol levels, and other serum chemistries. Am J Epidemiol 1990; 131: 1017-27.
31. Rathmann W, Funkhouser E, Dyer AR, Roseman JM. Relations of hyperuricaemia with the various components of the insulin resistance syndrome in young black and white adults: The CARDIA Study. Ann Epidemiol 1998; 8: 250-61.
32. Facchini F, Chen YDI, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance and plasma uric concentration. JAMA 1991; 266: 3008-9.
33. Cappuccio FP, Strazzulo P, Farinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling: results from a population-based study. JAMA 1993; 270: 354-9.
34. Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. Am J Epidemiol 1995; 142: 288-94.
35. Staessen J. The Determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly Trial. Am J Med 1991; 90 (suppl 3A): 50S-3S.
36. Frost PH, Davis BP, Burlando AJ, Curb JD, Guthrie GP, Isaacsohn JL, et al. Coronary heart disease risk factors in men and women aged 60 years and older. Findings from the Systolic Hypertension in the Elderly Program. Circulation 1996; 94: 26-34.
37. Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999; 34: 144-50.
38. Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P, et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the Piuma Study. Hypertension 2000; 36: 1072.
39. Franse LV, Pahor M, di Bari M, Shorr RI, Wan JY, Somes GW, et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens 2000; 18: 1149-54.
40. Wang JG, Staessen JA, Fagard RH, Birkenhager WH, Gong L, Liu L, for the Systolic Hypertension in China (Syst-China) Trial Collaborative Group. Hypertension 2001; 37: 1069-74.
41. Bickel C, Rupprecht HJ, Blankenberg S, Rippin G, Hafner G, Daunhauer A, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002; 89: 12-7.
42. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic functional and haemodynamic staging. Circulation 2003; 107: 1991-7.
43. Wong KYK, MacWalter RS, Fraser HW, Crombie I, Ogston SA, Struthers AD. Urate predicts subsequent cardiac death in stroke survivors. Eur Heart J 2002; 23: 788-93.
44. Weir CJ, Muir SW, Walters MR, Lees KR. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003; 34: 1951-7.
45. Lehto S, Niskanen L, Ronnema T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1998; 29: 635-9.
46. Mustard JF, Murphy EA, Ogrzylo MA, Smythe HA. Blood coagulation and platelet economy in subjects with primary gout. Can Med Assoc J 1963; 89: 1207-11.
47. Newland H. Hyperuricaemia in coronary cerebral and peripheral arterial disease: an explanation. Med Hypotheses 1975; 1: 152-5.
48. Ward HJ. Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998; 352: 670-1.
49. Becker BF. Towards the physiological finiction of uric acid. Free Radical Biol Med 1993; 14: 615-31.
50. Leyva F, Anker S, Swan JW, Godsland IF, Wingrove CS, Chua TP, et al. Serum uric acid as an impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997; 18: 858-65.
51. Bengtsson C, Lapidus Stendhal C, Waldenstrom J. Hyperuricaemia and risk of cardiovascular disease and overall death: A 12 year follow-up study of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand 1988; 224: 549-55.
52. Iribarren C, Folsom Aft, Eckfeldt JH, McGovern PG, Nieto FJ. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: The ARIC Study. Ann Epidemiol 1996; 6: 331-40.
53. Gotfredsen A, McNair P, Christiansen C Transbol I. Renal hypouricaemia in insulin treated diabetes mellitus. Clin Chim Acta 1982; 120: 355-61.
54. Wannamethee SG, Shaper AG, Durrington PN, Perry IJ. Hypertension, serum insulin, obesity and the metabolic syndrome. J Hum Hypertens 1998; 12: 735-41.
55. Messerli FH, Frohlich ED, Dreslinski GF, Suarez DH, Aristimuno GG. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Int Med 1980; 93: 817-21.
56. Frohlic ED. Uric acid: a risk factor for coronary heart disease JAMA 1993; 270: 378-9.
57. Kinsey D, Walther R, Sise HS, Whitelaw G, Smithwick R. Incidence of hyperuricaemia in 400 hypertension patients. Circulation 1961; 24: 972-3.
58. Zalokar J, Lellouch J, Claude JR, Kuntz D. Epidemiology of serum uric acid and gout in Frenchmen. J Chron Dis 1974; 27: 59-75.
59. Bengtsson C. Elevated serum uric acid during treatment with antihypertensive drugs. Acta Med Scand (Suppl) 1979; 628: 69-71.
60. Reaven GM. The Kidney: an unwilling accomplice in syndrome X. Am J Kidney Dis 1997; 30: 928-31.
61. Krentz AJ. Insulin resistance. BMJ 1996; 313: 1385-9.
62. Modan M, Halkin H, Karasik A, Lusky A. Elevated serum uric acid- a facet of hyperinsulinaemia. Diabetologia 1987; 30: 713-8.
63. Fox IH, John D, DeBruyne S, Marliss EB. Hyperuricaemia and hypertriglyceridaemia: metabolic basis for the association. Metabolism 1985; 34: 741-6.
64. Hoeschen RJ. Oxidative stress and cardiovascular disease. Can J Cardiol 1997; 13: 1021-5.
65. De Scheerder I, van de Kraay AM, Lamers JM, Koster JF, de Jong JW, Serruys PW, et al. Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during coronary angioplasty: potential mechanisms for free radical generation. Am J Cardiol 1991; 68: 392-5.
66. Langford HG, Blaufox MD, Borhani NO, Curb JD, Molteini A, Schneider KA, et al. Is Thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program. Arch Intern Med 1987; 147: 645-9.
67. Waring WS, Adwani SH, Breukels O, Webb DJ, Maxwell SRJ. Hyperuricaemia does not impair cardiovascular function in healthy adults. Heart 2004; 90: 155-9.
68. Schlesinger N. Dietary Factors and Hyperuricaemia. Curr Pharm Design 2005; 11(32): 4133-38.
69. Schachter M. Uric acid, hypertension and dyslipidaemia. Curr Pharm Design 2005; 11(32): 4139-43.
70. Daskalopoulou SS, Tzovaras V, Mikhailidis DP, Elisaf M. Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia. Curr Pharm Design 2005; 11(32): 4161-75.
71. Carbonin P, Zuccala G, Marzetti E, Lo Monaco MR. Coronary risk factors in the elderly: their interactions and treatment. Curr Pharm Design 2003; 9(29): 2465-78.
72. Gould WR, Leadley RJ. Recent advances in the discovery and development of direct coagulation factor Xa inhibitors. Curr Pharm Design 2003; 9(28): 2337-47.
73. Graf J, Janssens U. Low-molecular weight heparins in percutaneous coronary interventions: current concepts, problems, and perspectives. Curr Pharm Design 2004; 10(4): 375-86.